News | April 11, 2026
Zydus improves ESG rating to 68, up from 66 last year
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
Punya Salila Srivastava commends sanitation, waste management and infection control measures, while inaugurating a new G+9 undergraduate girls’ hostel
Former Global Head of IT & Digital Transformation at Biocon Biologics steps into enterprise-wide technology leadership role
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
A major highlight of the event was the launch of several publications and digital initiatives, including a certification course on the Ayush Grid portal
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
